American Funds EuroPacific Growth's management talent, strong analytical resources, and flexible approach make it one of the most attractive options within the foreign large-growth Morningstar Category.
American Funds Europacific Growth R1 RERAX
- NAV / 1-Day Return 57.11 / +2.22 %
- Total Assets 138.8 Bil
-
Adj. Expense Ratio
- Expense Ratio 1.570%
- Distribution Fee Level Average
- Share Class Type Retirement, Small
- Category Foreign Large Growth
- Investment Style Large Growth
- Min. Initial Investment 250
- Status Open
- TTM Yield 0.95%
- Turnover 30%
USD | NAV as of Sep 26, 2024 | 1-Day Return as of Sep 26, 2024, 10:17 PM GMT+0
Morningstar’s Analysis RERAX
Will RERAX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 25.1
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Novo Nordisk A/S Class B | 5.29 | 7.2 Bil | Healthcare |
Taiwan Semiconductor Manufacturing Co Ltd | 4.52 | 6.1 Bil | Technology |
Capital Group Central Cash Fund | 3.37 | 4.6 Bil | Cash and Equivalents |
SAP SE | 2.15 | 2.9 Bil | Technology |
ASML Holding NV | 2.13 | 2.9 Bil | Technology |
Reliance Industries Ltd | 2.08 | 2.8 Bil | Energy |
Airbus SE | 2.03 | 2.8 Bil | Industrials |
Safran SA | 1.95 | 2.7 Bil | Industrials |
Daiichi Sankyo Co Ltd | 1.79 | 2.4 Bil | Healthcare |
Glencore PLC | 1.62 | 2.2 Bil | Basic Materials |